Vanguard Group Inc Theravance Biopharma, Inc. Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,211,582 shares of TBPH stock, worth $38.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,211,582
Previous 2,157,430 2.51%
Holding current value
$38.5 Million
Previous $23.8 Million 35.69%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
BUY
$10.9 - $14.6 $590,256 - $790,619
54,152 Added 2.51%
2,211,582 $32.3 Million
Q2 2025

Aug 11, 2025
BUY
$8.32 - $11.25 $640,365 - $865,878
76,967 Added 3.7%
2,157,430 $23.8 Million
Q1 2025

May 09, 2025
BUY
$8.44 - $10.47 $590,116 - $732,051
69,919 Added 3.48%
2,080,463 $18.6 Million
Q4 2024

Feb 11, 2025
SELL
$7.93 - $10.08 $326,279 - $414,741
-41,145 Reduced 2.01%
2,010,544 $18.9 Million
Q3 2024

Nov 13, 2024
BUY
$7.66 - $10.25 $379,246 - $507,477
49,510 Added 2.47%
2,051,689 $16.5 Million
Q2 2024

Aug 13, 2024
SELL
$8.29 - $9.92 $5.67 Million - $6.78 Million
-683,674 Reduced 25.45%
2,002,179 $17 Million
Q1 2024

May 10, 2024
SELL
$8.22 - $11.59 $6.6 Million - $9.31 Million
-803,409 Reduced 23.03%
2,685,853 $24.1 Million
Q4 2023

Feb 14, 2024
SELL
$8.58 - $11.4 $3 Million - $3.99 Million
-350,067 Reduced 9.12%
3,489,262 $39.2 Million
Q3 2023

Nov 14, 2023
SELL
$8.38 - $10.44 $3.18 Million - $3.96 Million
-379,627 Reduced 9.0%
3,839,329 $33.1 Million
Q2 2023

Aug 14, 2023
SELL
$10.16 - $11.92 $14.3 Million - $16.8 Million
-1,407,770 Reduced 25.02%
4,218,956 $43.7 Million
Q1 2023

May 15, 2023
BUY
$9.87 - $11.44 $670,044 - $776,627
67,887 Added 1.22%
5,626,726 $61 Million
Q4 2022

Feb 10, 2023
SELL
$9.65 - $11.34 $4.32 Million - $5.07 Million
-447,294 Reduced 7.45%
5,558,839 $62.4 Million
Q3 2022

Nov 14, 2022
SELL
$8.39 - $10.22 $4.52 Million - $5.51 Million
-538,673 Reduced 8.23%
6,006,133 $60.9 Million
Q2 2022

Aug 12, 2022
SELL
$8.41 - $10.34 $3.39 Million - $4.17 Million
-403,141 Reduced 5.8%
6,544,806 $59.3 Million
Q1 2022

May 13, 2022
BUY
$8.33 - $12.96 $5.4 Million - $8.4 Million
648,124 Added 10.29%
6,947,947 $66.4 Million
Q4 2021

Feb 14, 2022
BUY
$7.42 - $11.05 $3.29 Million - $4.9 Million
443,268 Added 7.57%
6,299,823 $69.6 Million
Q3 2021

Nov 12, 2021
BUY
$6.77 - $14.41 $3.91 Million - $8.32 Million
577,586 Added 10.94%
5,856,555 $43.3 Million
Q2 2021

Aug 13, 2021
BUY
$14.52 - $22.46 $76.7 Million - $119 Million
5,278,969 New
5,278,969 $76.7 Million

Others Institutions Holding TBPH

# of Institutions
170
Shares Held
50.5M
Call Options Held
36.5K
Put Options Held
147K
View Full List

About Theravance Biopharma, Inc.

TBPH Quotes by TradingView
  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $1.16B
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email